The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
AMERICA

Ohio Pharmacy Board Reverses Ban on Hydroxychloroquine for COVID-19

Ohio Pharmacy Board Reverses Ban on Hydroxychloroquine for COVID-19
Ohio Gov. Mike DeWine speaks to mourners at a memorial service in the Oregon District held to recognize the victims of an early-morning mass shooting in the popular nightspot on Aug. 04, 2019 in Dayton, Ohio. Scott Olson/Getty Images
Tom Ozimek
Tom Ozimek
Reporter
7/30/2020|Updated: 7/30/2020

Ohio Gov. Mike DeWine called on the Ohio Board of Pharmacy to reverse its new ban on hydroxychloroquine for the treatment of COVID-19 infections, and the Board withdrew the proposed rule.

DeWine, a Republican, said in a statement that he believes, as does Dr. Steven Hahn, Commissioner of the Food and Drug Administration (FDA), that the matter of prescribing the drug is an individual health issue best settled between a doctor and a patient.

Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Author’s Selected Articles

Trump Says US Ready to Help Iranian Protesters as Death Toll Rises

Jan 10, 2026
Trump Says US Ready to Help Iranian Protesters as Death Toll Rises

Trump Declares National Emergency to Shield Venezuelan Oil Revenues Held in US Custody

Jan 10, 2026
Trump Declares National Emergency to Shield Venezuelan Oil Revenues Held in US Custody

Iran Protests Persist as Authorities Escalate Crackdown; Trump Warns Against Deadly Force

Jan 10, 2026
Iran Protests Persist as Authorities Escalate Crackdown; Trump Warns Against Deadly Force

Treasury Targets Somali-Linked Fraud in Minnesota Amid Terrorist Financing Concerns

Jan 09, 2026
Treasury Targets Somali-Linked Fraud in Minnesota Amid Terrorist Financing Concerns
Related Topics
Mike DeWine
hydroxychloroquine
ohio pharmarcy board
Add to My List
Save
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.